Detalhe da pesquisa
1.
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Oncology (Williston Park)
; 37(4): 176-183, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104758
2.
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Lancet Oncol
; 21(8): 1066-1076, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653053
3.
Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
JCO Precis Oncol
; 8: e2300513, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354330
4.
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
J Clin Oncol
; 41(33): 5140-5150, 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561967
5.
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
JCO Precis Oncol
; 7: e2300279, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039429
6.
SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.
Invest New Drugs
; 30(4): 1646-51, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21748296
7.
A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01).
Cancer Res Commun
; 2(10): 1188-1196, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36969746
8.
Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update.
J Clin Oncol
; 40(8): 892-910, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34936379
9.
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336).
Invest New Drugs
; 27(5): 469-75, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18941712
10.
Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline.
J Clin Oncol
; 37(16): 1436-1447, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30986117
11.
What's causing this woman's chest pain?
Gastroenterology
; 138(1): e1-2, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19932664
12.
First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma.
Clin Cancer Res
; 19(4): 920-8, 2013 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23362325
13.
Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414).
J Thorac Oncol
; 7(5): 906-12, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22481235
14.
Phase I study of bosutinib, a src/abl tyrosine kinase inhibitor, administered to patients with advanced solid tumors.
Clin Cancer Res
; 18(4): 1092-100, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22179664
15.
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.
Cancer Chemother Pharmacol
; 68(6): 1595-602, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21556747
16.
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma.
J Clin Oncol
; 29(34): 4555-60, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22025151
17.
Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: a phase II Southwest Oncology Group Study (S0415).
J Thorac Oncol
; 5(9): 1472-6, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20631636
18.
Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.
J Clin Oncol
; 24(25): 4069-77, 2006 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16943524